Page last updated: 2024-09-03

muramylnac-ala-isogln-lys-tripeptide and phorbol 12,13-dibutyrate

muramylnac-ala-isogln-lys-tripeptide has been researched along with phorbol 12,13-dibutyrate in 1 studies

Compound Research Comparison

Studies
(muramylnac-ala-isogln-lys-tripeptide)
Trials
(muramylnac-ala-isogln-lys-tripeptide)
Recent Studies (post-2010)
(muramylnac-ala-isogln-lys-tripeptide)
Studies
(phorbol 12,13-dibutyrate)
Trials
(phorbol 12,13-dibutyrate)
Recent Studies (post-2010) (phorbol 12,13-dibutyrate)
50412,803167

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eppenberger, U; Fabbro, D; Matter, A; Meyer, T1

Other Studies

1 other study(ies) available for muramylnac-ala-isogln-lys-tripeptide and phorbol 12,13-dibutyrate

ArticleYear
The lipophilic muramyltripeptide MTP-PE, a biological response modifier, is an activator of protein kinase C.
    Biochemical and biophysical research communications, 1986, Nov-14, Volume: 140, Issue:3

    Topics: Acetylmuramyl-Alanyl-Isoglutamine; Caenorhabditis elegans Proteins; Carrier Proteins; Cell Line; Enzyme Activation; ErbB Receptors; Phorbol 12,13-Dibutyrate; Phorbol Esters; Phosphatidylethanolamines; Protein Kinase C; Receptors, Drug; Receptors, Immunologic

1986